HER2+ Lung Cancer Breakthroughs: New Targeted Therapies Explained

from Medical News Podcast · host PeerDirect Publishing

Drs. Herzberg and Yu explore emerging clinical data from the 2025 meetings of the European Society For Medical Oncology (ESMO) and World Conference on Lung Cancer (WCLC), highlighting recent advancements in HER2-targeted therapies for NSCLC. Their discussion focuses on new drugs (eg, zongertinib and trastuzumab deruxtecan), their efficacy and safety profiles, and the potential for treating HER2 mutations and overexpression.

Episode metadata supplied by the publisher feed · Published Dec 26, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

HER2+ Lung Cancer Breakthroughs: New Targeted Therapies Explained

0:00 8:24

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medical News Podcast?

This episode is 8 minutes long.

When was this Medical News Podcast episode published?

This episode was published on December 26, 2025.

Can I download this Medical News Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!